Case report: peritonitis by Penicillium spp. in a patient undergoing continuous ambulatory peritoneal dialysis.
Even though prominent technical improvements in continuous ambulatory peritoneal dialysis (CAPD) treatments during the last decade, peritonitis keeps its place as an important cause of morbidity and mortality in these patients. Among them fungal peritonitis is happened to be the most difficult one to deal with and comes out serious clinical presentation. It is presented here a case of CAPD related fungal peritonitis caused by Penicillium spp. This case experienced recently relapsing bacterial episodes of peritonitis and received long term antibiotics intraperitoneally and systemically. Eventually, Penicillium spp. was detected in several cultures of peritoneal effluent and also tip of Tenckhoff catheter, therefore it was considered as a causative agent. Then, the catheter was removed and amphotericin B therapy was performed. But the general condition of the patient did not improve till surgically drainage of peritoneal collection which was determined by MR (Magnetic Resonance) examination of abdomen after antifungal treatment was completed and Penicillium spp. in the drainage samples was not determined anymore.
Keceli
S
S
Department of Microbiology and Clinical Microbiology, Medical Faculty of Kocaeli University, Kocaeli, Turkey. z.sema@mailcity.com
Yegenaga
I
I
Dagdelen
N
N
Mutlu
B
B
Uckardes
H
H
Willke
A
A
D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002404:Catheterization; D004322:Drainage; D004866:Equipment Contamination; D006801:Humans; D008297:Male; D009181:Mycoses / Q000209:etiology*; D010407:Penicillium / Q000302:isolation & purification*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000382:microbiology* / Q000628:therapy
D000935:Antifungal Agents; D000666:Amphotericin B